238 related articles for article (PubMed ID: 32885400)
1. Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer.
Quintanar T; Font C; Gallardo E; Barba R; Obispo B; Díaz-Pedroche C
Clin Transl Oncol; 2021 Apr; 23(4):697-708. PubMed ID: 32885400
[TBL] [Abstract][Full Text] [Related]
2. [Consensus on hereditary cancer between the Spanish Oncology Society and the primary care societies].
Robles L; Balmaña J; Barrel I; Grandes S; Graña B; Guillén C; Marcos H; Ramírez D; Redondo E; Sánchez J
Semergen; 2013; 39(5):259-66. PubMed ID: 23834976
[TBL] [Abstract][Full Text] [Related]
3. Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology).
Muñoz-Langa J; Jimenez-Fonseca P; Carmona-Bayonas A; de Castro EM; Pérez-Segura P; Cánovas MS; Gomez D; Moran LO; de Tejada MBG; Seguí E; López GB; Adrián SG; Campos MC; Olmos VP; Portero BO; Moyano MS; Crespo JAS; Sánchez LT; Rebollo MA; Rivas PO; Altozano JP; Lescure ÁR; Muñoz-Martín A
Clin Transl Oncol; 2021 Apr; 23(4):799-811. PubMed ID: 32789772
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of rivaroxaban use in patients with gynecologic malignancies at an academic medical center: A pilot study.
Signorelli JR; Gandhi AS
J Oncol Pharm Pract; 2019 Mar; 25(2):362-368. PubMed ID: 29157146
[TBL] [Abstract][Full Text] [Related]
5. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations.
López-Fernández T; Martín-García A; Roldán Rabadán I; Mitroi C; Mazón Ramos P; Díez-Villanueva P; Escobar Cervantes C; Alonso Martín C; Alonso Salinas GL; Arenas M; Arrarte Esteban VI; Ayala de La Peña F; Castro Fernández A; García Pardo H; García-Sanz R; González Porras JR; López de Sá E; Lozano T; Marco Vera P; Martínez Marín V; Mesa Rubio D; Montero Á; Oristrell G; Pérez de Prado A; Velasco Del Castillo S; Virizuela Echaburu JA; Zatarain-Nicolás E; Anguita Sánchez M; Tamargo Menéndez J;
Rev Esp Cardiol (Engl Ed); 2019 Sep; 72(9):749-759. PubMed ID: 31405794
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary consensus on cancer management during pregnancy.
Cubillo A; Morales S; Goñi E; Matute F; Muñoz JL; Pérez-Díaz D; de Santiago J; Rodríguez-Lescure Á
Clin Transl Oncol; 2021 Jun; 23(6):1054-1066. PubMed ID: 33191439
[TBL] [Abstract][Full Text] [Related]
7. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
[TBL] [Abstract][Full Text] [Related]
8. [The role of direct oral anticoagulants in the management of cancer-associated thrombosis in 2020].
Auditeau C; Talbot A; Blandinières A; Smadja DM; Gendron N
Bull Cancer; 2020 May; 107(5):574-585. PubMed ID: 32252973
[TBL] [Abstract][Full Text] [Related]
9. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
[TBL] [Abstract][Full Text] [Related]
10. Apixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial.
McBane Ii R; Loprinzi CL; Ashrani A; Perez-Botero J; Leon Ferre RA; Henkin S; Lenz CJ; Le-Rademacher JG; Wysokinski WE
Thromb Haemost; 2017 Oct; 117(10):1952-1961. PubMed ID: 28837207
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.
Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C
PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142
[TBL] [Abstract][Full Text] [Related]
12. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer.
Wang Y; Wang M; Ni Y; Liang Z
Hematology; 2020 Dec; 25(1):63-70. PubMed ID: 31984870
[No Abstract] [Full Text] [Related]
13. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
[TBL] [Abstract][Full Text] [Related]
14. [Sharing experience in venous thromboembolism management].
Yannoutsos A; Priollet P
J Med Vasc; 2018 May; 43(3):153-154. PubMed ID: 29754724
[No Abstract] [Full Text] [Related]
15. DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis.
Mai V; Tanguay VF; Guay CA; Bertoletti L; Magnan S; Turgeon AF; Lacasse Y; Lega JC; Provencher S
J Thromb Thrombolysis; 2020 Oct; 50(3):661-667. PubMed ID: 32052314
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.).
Kreher S; Ochsenreither S; Trappe RU; Pabinger I; Bergmann F; Petrides PE; Koschmieder S; Matzdorff A; Tiede A; Griesshammer M; Riess H; ; ;
Ann Hematol; 2014 Dec; 93(12):1953-63. PubMed ID: 25307456
[TBL] [Abstract][Full Text] [Related]
17. Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?
Carrier M; Wang TF
Blood; 2020 Aug; 136(6):669-673. PubMed ID: 32575112
[TBL] [Abstract][Full Text] [Related]
18. Use of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients With Cancer.
Soff GA
J Natl Compr Canc Netw; 2018 May; 16(5S):670-673. PubMed ID: 29784753
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
20. [HCF-ANMCO/AICPR/GIEC/ITAHFA/SICOA/SICP/SIMG/SIT Cardiological Societies Council Consensus document: Anticoagulant therapy in venous thromboembolism and atrial fibrillation of the patient with cancer. Current knowledge and new evidence].
Gulizia Chairperson MM; Parrini Co-Chairperson I; Colivicchi Co-Chairperson F; Bisceglia I; Caiazza F; Gensini GF; Mureddu GF; Santomauro M; Ageno W; Ambrosetti M; Aspromonte N; Barni S; Bellocci F; Caldarola P; Carletti M; De Luca L; Di Fusco SA; Di Lenarda A; Di Nisio M; Domenicucci S; Enea I; Francese GM; Lestuzzi C; Lucà F; Maurea N; Nassiacos D; Pedretti RFE; Pusineri E; Roscio G; Rossini R; Russo A; Volterrani M; Gabrielli Co-Chairperson D
G Ital Cardiol (Rome); 2020 Sep; 21(9):687-738. PubMed ID: 33094745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
